First Time Loading...
B

Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 14.5 USD 1.26%
Updated: Apr 19, 2024

Intrinsic Value

Bausch + Lomb Corp is a CA-based company operating in Health Care Equipment & Supplies industry. [ Read More ]

The intrinsic value of one BLCO stock under the Base Case scenario is 25.85 USD. Compared to the current market price of 14.5 USD, Bausch + Lomb Corp is Undervalued by 44%.

Key Points:
BLCO Intrinsic Value
Base Case
25.85 USD
Undervaluation 44%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Bausch + Lomb Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BLCO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Bausch + Lomb Corp

Provide an overview of the primary business activities
of Bausch + Lomb Corp.

What unique competitive advantages
does Bausch + Lomb Corp hold over its rivals?

What risks and challenges
does Bausch + Lomb Corp face in the near future?

Has there been any significant insider trading activity
in Bausch + Lomb Corp recently?

Summarize the latest earnings call
of Bausch + Lomb Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bausch + Lomb Corp.

Provide P/S
for Bausch + Lomb Corp.

Provide P/E
for Bausch + Lomb Corp.

Provide P/OCF
for Bausch + Lomb Corp.

Provide P/FCFE
for Bausch + Lomb Corp.

Provide P/B
for Bausch + Lomb Corp.

Provide EV/S
for Bausch + Lomb Corp.

Provide EV/GP
for Bausch + Lomb Corp.

Provide EV/EBITDA
for Bausch + Lomb Corp.

Provide EV/EBIT
for Bausch + Lomb Corp.

Provide EV/OCF
for Bausch + Lomb Corp.

Provide EV/FCFF
for Bausch + Lomb Corp.

Provide EV/IC
for Bausch + Lomb Corp.

Show me price targets
for Bausch + Lomb Corp made by professional analysts.

What are the Revenue projections
for Bausch + Lomb Corp?

How accurate were the past Revenue estimates
for Bausch + Lomb Corp?

What are the Net Income projections
for Bausch + Lomb Corp?

How accurate were the past Net Income estimates
for Bausch + Lomb Corp?

What are the EPS projections
for Bausch + Lomb Corp?

How accurate were the past EPS estimates
for Bausch + Lomb Corp?

What are the EBIT projections
for Bausch + Lomb Corp?

How accurate were the past EBIT estimates
for Bausch + Lomb Corp?

Compare the revenue forecasts
for Bausch + Lomb Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bausch + Lomb Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bausch + Lomb Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bausch + Lomb Corp compared to its peers.

Compare the P/E ratios
of Bausch + Lomb Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Bausch + Lomb Corp with its peers.

Analyze the financial leverage
of Bausch + Lomb Corp compared to its main competitors.

Show all profitability ratios
for Bausch + Lomb Corp.

Provide ROE
for Bausch + Lomb Corp.

Provide ROA
for Bausch + Lomb Corp.

Provide ROIC
for Bausch + Lomb Corp.

Provide ROCE
for Bausch + Lomb Corp.

Provide Gross Margin
for Bausch + Lomb Corp.

Provide Operating Margin
for Bausch + Lomb Corp.

Provide Net Margin
for Bausch + Lomb Corp.

Provide FCF Margin
for Bausch + Lomb Corp.

Show all solvency ratios
for Bausch + Lomb Corp.

Provide D/E Ratio
for Bausch + Lomb Corp.

Provide D/A Ratio
for Bausch + Lomb Corp.

Provide Interest Coverage Ratio
for Bausch + Lomb Corp.

Provide Altman Z-Score Ratio
for Bausch + Lomb Corp.

Provide Quick Ratio
for Bausch + Lomb Corp.

Provide Current Ratio
for Bausch + Lomb Corp.

Provide Cash Ratio
for Bausch + Lomb Corp.

What is the historical Revenue growth
over the last 5 years for Bausch + Lomb Corp?

What is the historical Net Income growth
over the last 5 years for Bausch + Lomb Corp?

What is the current Free Cash Flow
of Bausch + Lomb Corp?

Financials

Balance Sheet Decomposition
Bausch + Lomb Corp

Current Assets 2.7B
Cash & Short-Term Investments 331m
Receivables 839m
Other Current Assets 1.6B
Non-Current Assets 10.7B
PP&E 1.4B
Intangibles 8.2B
Other Non-Current Assets 1.1B
Current Liabilities 1.6B
Accounts Payable 522m
Accrued Liabilities 627m
Other Current Liabilities 430m
Non-Current Liabilities 5B
Long-Term Debt 4.5B
Other Non-Current Liabilities 481m
Efficiency

Earnings Waterfall
Bausch + Lomb Corp

Revenue
4.1B USD
Cost of Revenue
-1.6B USD
Gross Profit
2.5B USD
Operating Expenses
-2.3B USD
Operating Income
213m USD
Other Expenses
-473m USD
Net Income
-260m USD

Free Cash Flow Analysis
Bausch + Lomb Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

BLCO Profitability Score
Profitability Due Diligence

Bausch + Lomb Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
48/100
Profitability
Score

Bausch + Lomb Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

BLCO Solvency Score
Solvency Due Diligence

Bausch + Lomb Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
33/100
Solvency
Score

Bausch + Lomb Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BLCO Price Targets Summary
Bausch + Lomb Corp

Wall Street analysts forecast BLCO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BLCO is 19.81 USD with a low forecast of 16.16 USD and a high forecast of 26.25 USD.

Lowest
Price Target
16.16 USD
11% Upside
Average
Price Target
19.81 USD
37% Upside
Highest
Price Target
26.25 USD
81% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BLCO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BLCO Price
Bausch + Lomb Corp

1M 1M
-8%
6M 6M
-13%
1Y 1Y
-13%
3Y 3Y
-19%
5Y 5Y
-19%
10Y 10Y
-19%
Annual Price Range
14.5
52w Low
13.68
52w High
20.99
Price Metrics
Average Annual Return -12.67%
Standard Deviation of Annual Returns
N/A
Max Drawdown -35%
Shares Statistics
Market Capitalization 5.1B USD
Shares Outstanding 351 000 000
Percentage of Shares Shorted 3.71%

BLCO Return Decomposition
Main factors of price return

What is price return decomposition?

BLCO News

Last Important Events
Bausch + Lomb Corp

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Bausch + Lomb Corp

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Bausch + Lomb Corp

Country

Canada

Industry

Health Care

Market Cap

5.1B USD

Dividend Yield

0%

Description

Bausch + Lomb Corp is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Vaughan, Ontario and currently employs 12,500 full-time employees. The company went IPO on 2022-05-06. Bausch + Lomb Corporation is a Canada-based eye health company. The firm offers lines of contact lenses, intraocular lenses (IOL), medical devices, surgical systems, vitamin and mineral supplements, lens care products, prescription eye-medications and over the counter (OTC) eye health consumer products. The company operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. Vision Care/Consumer Health Care business includes both contact lens and consumer eye care businesses, and includes products, such as Biotrue ONEday daily disposables. Ophthalmic Pharmaceuticals business includes a range of pharmaceutical products for post-operative treatments and treatments for eye conditions, such as glaucoma, eye inflammation, ocular hypertension, and retinal disease. Surgical business includes medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions.

Contact

ONTARIO
Vaughan
520 Applewood Crescent
+19082552864
https://www.bausch.com/

IPO

2022-05-06

Employees

12 500

Officers

Executive VP & CFO
Mr. Osama A. Eldessouky
Executive VP of Research & Development and Chief Medical officer
Dr. Yehia Hashad M.D.
CEO & Chairman
Mr. Brenton L. Saunders J.D.
Executive VP and Chief Supply Chain & Operations Officer
Mr. Alan Waterhouse CPFA, MBA
Senior VP, Controller & Chief Accounting Officer
Mr. Frederick J. Munsch
Executive VP & Chief Legal Officer
Mr. A. Robert D. Bailey
Show More
Chief Compliance Officer
Mr. Jonathon L. Kellerman
Chief Communications Officer
T.J. Crawford
Chief Corporate Development & Digital Officer
Dr. Manisha A. Narasimhan Ph.D.
Executive VP & Chief Human Resources Officer
Ms. Asli Gevgilili
Show Less

See Also

Discover More
What is the Intrinsic Value of one BLCO stock?

The intrinsic value of one BLCO stock under the Base Case scenario is 25.85 USD.

Is BLCO stock undervalued or overvalued?

Compared to the current market price of 14.5 USD, Bausch + Lomb Corp is Undervalued by 44%.